Status:
COMPLETED
Efficacy and Tolerability of Angeliq in Thai Women
Lead Sponsor:
Bayer
Conditions:
Postmenopause
Eligibility:
FEMALE
45+ years
Phase:
PHASE4
Brief Summary
To evaluate the safety, tolerability, and efficacy of Angeliq in Thai post menopausal women with hot flushes and other climacteric symptoms.
Detailed Description
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany. Bayer Schering Pharma AG, Germany is the sponsor of the trial...
Eligibility Criteria
Inclusion
- Postmenopausal women with hot flushes
Exclusion
- Women with a contraindication for Hormone Replacement Therapy (HRT)
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT00185328
Start Date
September 1 2005
End Date
December 1 2006
Last Update
December 12 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.